Synthorx INC (THOR) Stock Price & Overview

NASDAQ:THOR

Current stock price

67.99
0 (0%)
Last:

The current stock price of THOR is 67.99 null. Today THOR is down by 0%. In the past month the price decreased by -0.04%. In the past year, price increased by 386.69%.

THOR Key Statistics

52-Week Range11.05 - 71.9
Current THOR stock price positioned within its 52-week range.
1-Month Range67.82 - 71.9
Current THOR stock price positioned within its 1-month range.
Market Cap
2.199B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.01
Dividend Yield
N/A

THOR Stock Performance

Today
0%
1 Week
-0.16%
1 Month
-0.04%
3 Months
+477.17%
Longer-term
6 Months +337.24%
1 Year +386.69%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

THOR Stock Chart

Synthorx INC / THOR Daily stock chart

THOR Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to THOR. When comparing the yearly performance of all stocks, THOR is one of the better performing stocks in the market, outperforming 99.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

THOR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to THOR. While THOR has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

THOR Earnings

Next Earnings DateN/A
Last Earnings DateN/A

THOR Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y76.63%
Revenue Next YearN/A

THOR Financial Highlights

Over the last trailing twelve months THOR reported a non-GAAP Earnings per Share(EPS) of -2.0100000000000002. The EPS decreased by -172.24% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-63.60M
Industry RankSector Rank
PM (TTM) N/A
ROA -38.86%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-172.24%
Revenue 1Y (TTM)N/A

THOR Ownership

Ownership
Inst Owners66.12%
Shares32.34M
Float157.91K
Ins Owners1.99%
Short Float %N/A
Short RatioN/A

About THOR

Company Profile

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.

Company Info

Synthorx INC

11099 North Torrey Pines Road Suite 190

La Jolla CA 92037

CEO: Laura Shawver

Phone: 858-750-4700

Synthorx INC / THOR FAQ

Can you describe the business of Synthorx INC?

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.


What is the stock price of Synthorx INC today?

The current stock price of THOR is 67.99 null.


Does THOR stock pay dividends?

THOR does not pay a dividend.


What is the ChartMill rating of Synthorx INC stock?

THOR has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the Price/Earnings (PE) ratio of Synthorx INC (THOR)?

Synthorx INC (THOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.01).


Should I buy THOR stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on THOR.